Use of Augmented Intelligence for the Interpretation of Bone Standard X-rays Prescribed by the Emergency Department (IMMEDIAT Urgences) (IMMEDIAT)

Intelligence for the Interpretation of Bone Standard X-rays Prescribed by the Emergency Department

The study evaluates, in 3 emergency departments (ED) and on randomized alternate periods, the use of SmartUrgences®, Augmented Intelligence (AI) software to help the interpretation of bone standard X-rays prescibed by the ED.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

"The study evaluates, in 3 emergency departments (ED) and on randomized alternate periods, the use of SmartUrgences®, Augmented Intelligence (AI) software to help the interpretation of bone radiographs prescibed by the ED.

The primary objective of the organizational study is to evaluate, compared to the current organization for the interpretation of standard bone radiographs requested by the ED, the impact of an organization incorporating the Milvue solution, on the reduction of the patient diagnostic error rate.

A cost-consequence study is carried out, comparing from the point of view of the community (production costs according to the HAS recommendations), the radiological diagnosis within the framework of an organization with the Milvue solution, to that within the framework of the current organization without the use of the Milvue solution.

The economic study will follow the scheme of the organizational study, comparing the periods with and without the Milvue solution and analyzing the costs and consequences, by period and by patient.

This is an open-label randomized cluster multiple period cross-over study with 6 alternate periods (3 with AI, 3 with usual organization) of 1 month in each ED. The choice of the intervention for the first period will be randomized."

Study Type

Interventional

Enrollment (Estimated)

8400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Paris, France, 75012
        • Recruiting
        • Hopital Saint Antoine
        • Contact:
          • ANNE Miquel
      • Paris, France, 75020
        • Recruiting
        • Hôpital Tenon
        • Contact:
          • HELENE GOULET
      • Paris, France, 75012
        • Recruiting
        • Hopital Salpetriere
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. All adult referred by the ED for a conventional X-rays of all or part of the appendicular skeleton and/or pelvis and/or costal gril
  2. Not opposed to participate"

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Organization
X-rays are done in the radiology department and the images are made available to emergency physicians without waiting for the radiologist's report, which is usually done on a delayed basis.
Other: Organization with AI
X-rays are done in the radiology department and the images are made available to emergency physicians with the AI interpretation. X-rays flagged by IA as anormal or suspicious will be reviewed without delay by the radiologist, non-flagged X-rays will be reviewed by radiologists on a delayed basis.
X-rays are done in the radiology department and the images are made available to emergency physicians with the AI interpretation. X-rays flagged by IA as anormal or suspicious will be reviewed without delay by the radiologist, non-flagged X-rays will be reviewed by radiologists on a delayed basis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic error rate
Time Frame: Through patient's discharge from the emergency department, an average of 1 day

A diagnostic error is defined as a final consensus diagnosis that differs from the diagnosis documented in the medical record by the emergency physician prior to patient's discharge from the ED.

A diagnostic error is defined as a final consensus diagnosis that differs from the diagnosis documented in the medical record by the emergency physician prior to patient's discharge from the ED.

Through patient's discharge from the emergency department, an average of 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time between x-ray and first diagnostic
Time Frame: Through patient's discharge from the emergency department, an average of 1 day
Time between x-ray and first diagnostic, either by the emergency physician or by the radiologist
Through patient's discharge from the emergency department, an average of 1 day
Time between x-ray and first diagnostic by the emergency physician
Time Frame: Through patient's discharge from the emergency department, an average of 1 day
Time between x-ray and first diagnostic by the emergency physician in the patient medical file
Through patient's discharge from the emergency department, an average of 1 day
Time between x-ray and final diagnostic by the emergency physician
Time Frame: 30 days
Time between x-ray and final diagnostic by the emergency physician in the patient medical file. A diagnostic will be considered as final if the same as the consensus one
30 days
Rate of X-rays interpretation by radiologist without delay
Time Frame: 1 hour
Rate of X-rays interpretation by radiologist without delay (i.e within 1 hour)
1 hour
Number of all radiological exam per patient prescribed by the ED
Time Frame: Through patient's discharge from the emergency department, an average of 1 day
Number of all radiological exam per patient prescribed by the ED (MRI, scanner, x-rays, echography)
Through patient's discharge from the emergency department, an average of 1 day
Number of X-rays with a report by a radiologist at 30 days
Time Frame: 30 days
Number of X-rays with a report by a radiologist at 30 days
30 days
Time spent in the ED by the patient
Time Frame: Through patient's discharge from the emergency department, an average of 1 day
Time spent in the ED by the patient
Through patient's discharge from the emergency department, an average of 1 day
Number of patients invited to come back in the ED
Time Frame: 30 days
Number of patients invited to come back in the ED
30 days
30 days morbidity
Time Frame: 30 days
New ED visit, hospitalization, radiological exam or outpatient visit, for the same reason as the first ED visit
30 days
Total cost from the hospital viewpoint
Time Frame: 30 days
Total cost from the hospital viewpoint
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 31, 2023

Primary Completion (Estimated)

December 15, 2023

Study Completion (Estimated)

December 15, 2023

Study Registration Dates

First Submitted

April 21, 2023

First Submitted That Met QC Criteria

May 26, 2023

First Posted (Actual)

May 31, 2023

Study Record Updates

Last Update Posted (Actual)

May 31, 2023

Last Update Submitted That Met QC Criteria

May 26, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 21OLE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Fracture

Clinical Trials on Organization with AI

3
Subscribe